Brian Schwartz - Net Worth and Insider Trading

Brian Schwartz Net Worth

The estimated net worth of Brian Schwartz is at least $564,740 dollars as of 2024-05-22. Brian Schwartz is the Chief Medical Officer of Arqule Inc and owns about 28,237 shares of Arqule Inc (ARQL) stock worth over $564,740. Details can be seen in Brian Schwartz's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Brian Schwartz has not made any transactions after 2012-06-06 and currently still holds the listed stock(s).

Transaction Summary of Brian Schwartz

Brian Schwartz Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Brian Schwartz owns 6 companies in total, including LifeSci Acquisition Corp (LSACU) , Arqule Inc (ARQL) , and Alaunos Therapeutics Inc (TCRT) among others .

Click here to see the complete history of Brian Schwartz’s form 4 insider trades.

Insider Ownership Summary of Brian Schwartz

Ticker	Comapny	Transaction Date	Type of Owner
LSACU	LifeSci Acquisition Corp	2020-03-05	director
ARQL	Arqule Inc	2020-01-16	See Remarks
TCRT	Alaunos Therapeutics Inc	2008-03-26	V.P. Chief Medical Officer
		2021-09-07	director
		2020-12-17	director
		2020-03-05	director

Brian Schwartz Latest Holdings Summary

Brian Schwartz currently owns a total of 1 stock. Brian Schwartz owns 28,237 shares of Arqule Inc (ARQL) as of June 6, 2012, with a value of $564,740.

Latest Holdings of Brian Schwartz

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
ARQL	Arqule Inc	2012-06-06	28,237	20.00	564,740

Holding Weightings of Brian Schwartz

Brian Schwartz Form 4 Trading Tracker

According to the SEC Form 4 filings, Brian Schwartz has made a total of 0 transactions in Arqule Inc (ARQL) over the past 5 years. The most-recent trade in Arqule Inc is the acquisition of 4,700 shares on June 6, 2012, which cost Brian Schwartz around $29,422.

Insider Trading History of Brian Schwartz

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Brian Schwartz Trading Performance

GuruFocus tracks the stock performance after each of Brian Schwartz's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Brian Schwartz is 1.19%. GuruFocus also compares Brian Schwartz's trading performance to market benchmark return within the same time period. The performance of stocks bought by Brian Schwartz within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Brian Schwartz's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Brian Schwartz

Average Return

Average return per transaction

Outperforming Transactions

2 out of 3 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	15.26
Relative Return to S&P 500(%)	14.7

Brian Schwartz Ownership Network

Ownership Network List of Brian Schwartz

No Data

Ownership Network Relation of Brian Schwartz

Brian Schwartz Owned Company Details

What does LifeSci Acquisition Corp do?

Who are the key executives at LifeSci Acquisition Corp?

Brian Schwartz is the director of LifeSci Acquisition Corp. Other key executives at LifeSci Acquisition Corp include 10 percent owner Rubric Capital Management Lp , 10 percent owner David Efraim Rosen , and Chief Technology Officer Xiaoming Zhang .

LifeSci Acquisition Corp (LSACU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of LifeSci Acquisition Corp (LSACU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of LifeSci Acquisition Corp (LSACU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

LifeSci Acquisition Corp (LSACU)'s detailed insider trading history can be found in Insider Trading Tracker table.

LifeSci Acquisition Corp Insider Transactions

No Available Data

What does Arqule Inc do?

Who are the key executives at Arqule Inc?

Brian Schwartz is the See Remarks of Arqule Inc. Other key executives at Arqule Inc include director & Chief Executive Officer Paolo Pucci , CFO and Treasurer Marc Schegerin , and 10 percent owner Merck & Co., Inc. .

Arqule Inc (ARQL) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Arqule Inc (ARQL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Arqule Inc (ARQL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Arqule Inc (ARQL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Arqule Inc Insider Transactions

No Available Data

What does Alaunos Therapeutics Inc do?

Who are the key executives at Alaunos Therapeutics Inc?

Brian Schwartz is the V.P. Chief Medical Officer of Alaunos Therapeutics Inc. Other key executives at Alaunos Therapeutics Inc include director & Chief Executive Officer Boyle Kevin S. Sr. , VP & Finance Michael Wong , and See Remarks Abhishek K Srivastava .

Alaunos Therapeutics Inc (TCRT) Insider Trades Summary

Over the past 18 months, Brian Schwartz made no insider transaction in Alaunos Therapeutics Inc (TCRT). Other recent insider transactions involving Alaunos Therapeutics Inc (TCRT) include a net purchase of 1,250,000 shares made by Jaime Vieser , a net purchase of 750,000 shares made by Robert W Postma , and a net sale of 68,014 shares made by Boyle Kevin S. Sr. .

In summary, during the past 3 months, insiders sold 0 shares of Alaunos Therapeutics Inc (TCRT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,534 shares of Alaunos Therapeutics Inc (TCRT) were sold and 133,333 shares were bought by its insiders, resulting in a net purchase of 128,799 shares.

Alaunos Therapeutics Inc (TCRT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Alaunos Therapeutics Inc Insider Transactions

No Available Data

What does Infinity Pharmaceuticals Inc do?

Who are the key executives at Infinity Pharmaceuticals Inc?

Brian Schwartz is the director of Infinity Pharmaceuticals Inc. Other key executives at Infinity Pharmaceuticals Inc include director & President & CEO Adelene Q Perkins , Chief Scientific Officer Stephane Peluso , and Chief Medical Officer Robert Jr. Ilaria .

Infinity Pharmaceuticals Inc (INFIQ) Insider Trades Summary

Over the past 18 months, Brian Schwartz made no insider transaction in Infinity Pharmaceuticals Inc (INFIQ). Other recent insider transactions involving Infinity Pharmaceuticals Inc (INFIQ) include a net sale of 410,196 shares made by Adelene Q Perkins ,

In summary, during the past 3 months, insiders sold 0 shares of Infinity Pharmaceuticals Inc (INFIQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 410,196 shares of Infinity Pharmaceuticals Inc (INFIQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 410,196 shares.

Infinity Pharmaceuticals Inc (INFIQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Infinity Pharmaceuticals Inc Insider Transactions

No Available Data

What does Cyclacel Pharmaceuticals Inc do?

Who are the key executives at Cyclacel Pharmaceuticals Inc?

Brian Schwartz is the director of Cyclacel Pharmaceuticals Inc. Other key executives at Cyclacel Pharmaceuticals Inc include director & President & C.E.O. Spiro Rombotis , director & E.V.P. & Finance & C.O.O. Paul Mcbarron , and Chief Medical Officer Mark Kirschbaum .

Cyclacel Pharmaceuticals Inc (CYCC) Insider Trades Summary

Over the past 18 months, Brian Schwartz made no insider transaction in Cyclacel Pharmaceuticals Inc (CYCC). Other recent insider transactions involving Cyclacel Pharmaceuticals Inc (CYCC) include a net purchase of 6,070 shares made by Spiro Rombotis , and a net purchase of 1,886 shares made by Paul Mcbarron .

In summary, during the past 3 months, insiders sold 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) were sold and 7,956 shares were bought by its insiders, resulting in a net purchase of 7,956 shares.

Cyclacel Pharmaceuticals Inc (CYCC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cyclacel Pharmaceuticals Inc Insider Transactions

No Available Data

What does Vincerx Pharma Inc do?

Who are the key executives at Vincerx Pharma Inc?

Brian Schwartz is the director of Vincerx Pharma Inc. Other key executives at Vincerx Pharma Inc include Chief Financial Officer Alexander A. Seelenberger , See Remarks Tom C Thomas , and director & 10 percent owner & President and CEO Ahmed Md Hamdy .

Vincerx Pharma Inc (VINC) Insider Trades Summary

Over the past 18 months, Brian Schwartz made no insider transaction in Vincerx Pharma Inc (VINC). Other recent insider transactions involving Vincerx Pharma Inc (VINC) include a net purchase of 57,580 shares made by Ahmed Md Hamdy , a net purchase of 45,214 shares made by Raquel E. Izumi , and a net purchase of 12,000 shares made by Tom C Thomas .

In summary, during the past 3 months, insiders sold 0 shares of Vincerx Pharma Inc (VINC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Vincerx Pharma Inc (VINC) were sold and 125,294 shares were bought by its insiders, resulting in a net purchase of 125,294 shares.

Vincerx Pharma Inc (VINC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Vincerx Pharma Inc Insider Transactions

No Available Data

Brian Schwartz Mailing Address

Above is the net worth, insider trading, and ownership report for Brian Schwartz. You might contact Brian Schwartz via mailing address: C/o Arqule, Inc., 1 Wall Street, 6th Floor, Burlington Ma 01803.

Discussions on Brian Schwartz

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.